LON:AREC Arecor Therapeutics (AREC) Share Price, News & Analysis → (Free Workshop) Advanced “bug-out bag” hacks! (From Warrior Life) (Ad) Free AREC Stock Alerts GBX 125.10 -2.40 (-1.88%) (As of 06/14/2024 07:40 PM ET) Add Compare Share Share Today's Range 125▼ 127.5050-Day Range 125.10▼ 16352-Week Range 103.50▼ 250Volume7,247 shsAverage Volume18,534 shsMarket Capitalization£38.32 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines Get Arecor Therapeutics alerts: Email Address Ad The Freeport SocietyBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.Click here now to see my urgent election warning. About Arecor Therapeutics Stock (LON:AREC)Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It also offers Ogluo, a ready-to-use glucagon auto-injector pen that is used to treat hypoglycaemia in patients with diabetes; and specialty hospital care products. In addition, the company is developing AT247, an ultra-rapid acting insulin for patients with Type I and Type II diabetics; and AT278, an ultra-concentrated rapid acting insulin formulation that has been designed to accelerate the absorption of insulin post injection. It has a research collaboration with TRx Biosciences Limited for the formulation development of an oral glucagon-like peptide-1 (GLP-1) receptor agonist product. The company was founded in 2007 and is headquartered in Little Chesterford, the United Kingdom.Read More AREC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AREC Stock News HeadlinesMay 20, 2024 | finance.yahoo.comAt278 Ultra-Concentrated Ultra-Rapid Acting Insulin Demonstrates Superiority in Phase i Clinical Trial in Overweight and Obese People With Type 2 DiabetesMay 9, 2024 | lse.co.ukArecor Therapeutics collaborates with Medtronic on novel insulinMay 9, 2024 | finanznachrichten.deArecor Therapeutics plc: Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump deliveryApril 23, 2024 | lse.co.ukArecor chief financial officer to leave in July after five yearsApril 18, 2024 | morningstar.comArecor Therapeutics PLC Ordinary Shares ARECApril 2, 2024 | lse.co.ukStrip Tinning shares up as hails "largest ever" glazing orderMarch 14, 2024 | finance.yahoo.comArecor Therapeutics announces collaboration on oral GLP-1 drug for diabetes and obesity treatmentMarch 12, 2024 | lse.co.ukArecor to develop "holy grail" diabetes treatment with partner TRxMarch 12, 2024 | finance.yahoo.comARECOR AND TRx BIOSCIENCES ESTABLISH RESEARCH COLLABORATION TO DEVELOP ORAL GLP-1 WITH ENHANCED BIOAVAILABILITYFebruary 16, 2024 | finance.yahoo.comArecor Therapeutics plc (AREC.L)February 1, 2024 | lse.co.ukArecor Therapeutics hails Arestat as 2023 performance "strong"January 20, 2024 | morningstar.comArecor Therapeutics PLC Ordinary SharesJanuary 18, 2024 | lse.co.ukTRADING UPDATES: Patent boosts for DG Innovate and Arecor TherapeuticsDecember 4, 2023 | lse.co.ukArecor inks co-development deal with global medical companyNovember 17, 2023 | finance.yahoo.comArecor Therapeutics takes major step with first commercial sale of AT220November 2, 2023 | lse.co.ukTRADING UPDATES: Troy Income suspends buyback of sharesSeptember 4, 2023 | lse.co.ukArecor Therapeutics subsidiary Tetris Pharma signs deal with GoodlifeAugust 17, 2023 | lse.co.ukArecor Therapeutics to collaborate with "top 10" pharmaceutical firmJuly 20, 2023 | marketwatch.comArecor Therapeutics Flags Strong 1H ProgressJuly 20, 2023 | finance.yahoo.comArecor: Business UpdateJune 3, 2023 | finance.yahoo.comShareholders in Arecor Therapeutics (LON:AREC) are in the red if they invested a year agoApril 24, 2023 | finance.yahoo.comArecor Therapeutics has "a strong basis to accelerate" growth strategyMarch 14, 2023 | finance.yahoo.comRecent uptick might appease Arecor Therapeutics plc (LON:AREC) institutional owners after losing 16% over the past yearDecember 1, 2022 | msn.comArecor to launch second Phase I clinical trial of AT278 rapid-acting insulin for diabetes patientNovember 10, 2022 | finance.yahoo.comEven after rising 12% this past week, Arecor Therapeutics (LON:AREC) shareholders are still down 43% over the past yearSee More Headlines Receive AREC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Arecor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:AREC CUSIPN/A CIKN/A Webwww.americanresourcescorp.com Phone44 1223 426 060FaxN/AEmployees51Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-8,550,000.00 Net Margins-187.05% Pretax MarginN/A Return on Equity-63.41% Return on Assets-30.88% Debt Debt-to-Equity Ratio3.55 Current Ratio2.17 Quick Ratio6.24 Sales & Book Value Annual Sales£4.57 million Price / Sales8.38 Cash FlowGBX 24.67 per share Price / Cash Flow5.07 Book ValueGBX 31 per share Price / Book4.04Miscellaneous Outstanding Shares30,630,000Free FloatN/AMarket Cap£38.32 million OptionableNot Optionable Beta-0.21 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesDr. Sarah Jennifer Howell Ph.D. (Age 49)CEO & Director Comp: $421kMs. Susan Day Lowther FCMA (Age 64)CFO, Company Secretary & Director Comp: $306kDr. Jan Jezek Ph.D.Chief Scientific OfficerMr. David GerringSenior Vice President of DevelopmentDr. Manjit Rahelu Ph.D.Chief Business OfficerKey CompetitorsAvacta GroupLON:AVCTCircassia GroupLON:CIRTiziana Life SciencesLON:TILSVerseonLON:VSNFutura MedicalLON:FUMView All Competitors AREC Stock Analysis - Frequently Asked Questions How have AREC shares performed in 2024? Arecor Therapeutics' stock was trading at GBX 182.50 at the beginning of the year. Since then, AREC stock has decreased by 31.5% and is now trading at GBX 125.10. View the best growth stocks for 2024 here. How do I buy shares of Arecor Therapeutics? Shares of AREC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:AREC) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored(Free Workshop) Advanced “bug-out bag” hacks!“Do you have a ‘bug-out bag’ (survival kit) ready to grab-and-go when a disaster or other crisis strikes?” ...Warrior Life | SponsoredSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the ...Crypto 101 Media | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arecor Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Arecor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.